I. Goderel

发表

Most probable number enumeration of H2-utilizing acetogenic bacteria from the digestive tract of animals and man.

J. Doré, P. Pochart, B. Morvan, 1995, FEMS microbiology letters.

Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors

V. de Lédinghen, J. Zucman‐Rossi, T. Asselah, 2022, JHEP reports : innovation in hepatology.

Enumeration of H2-utilizing methanogenic archaea, acetogenic and sulfate-reducing bacteria from human feces

J. Doré, P. Pochart, A. Bernalier, 1995 .

Interrelations between populations of methanogenic archaea and sulfate-reducing bacteria in the human colon.

J. Doré, P. Pochart, J. Rambaud, 1992, FEMS microbiology letters.

Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

V. de Lédinghen, J. Zucman‐Rossi, T. Asselah, 2022, Journal of Cannabis Research.

Pyxigraphic sampling to enumerate methanogens and anaerobes in the right colon of healthy humans.

B. Flourié, P. Pochart, J. Rambaud, 1993, Gastroenterology.

Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY)

F. Carrat, S. Pol, D. Sène, 2007, AIDS.

Fecal recovery in humans of viable Bifidobacterium sp ingested in fermented milk.

P. Marteau, P. Pochart, Y. Bouhnik, 1992, Gastroenterology.

Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy.

F. Carrat, S. Pol, P. Cacoub, 2008, Journal of hepatology.

Interrelations between populations of methanogenic archaea and sulfate-reducing bacteria in the human colon.

J. Doré, P. Pochart, J. Rambaud, 1992, FEMS microbiology letters.

Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France

P. Vanhems, Y. Yazdanpanah, F. Carrat, 2016, Clinical Microbiology and Infection.

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

V. de Lédinghen, T. Asselah, D. Thabut, 2021, BMC Infectious Diseases.

[Survival of Lactobacillus acidophilus and Bifidobacterium sp. in the small intestine following ingestion in fermented milk. A rational basis for the use of probiotics in man].

P. Pochart, Y. Bouhnik, P. Marteau, 1992, Gastroenterologie clinique et biologique.

Survival of bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion.

P. Pochart, Y. Bouhnik, P. Marteau, 1992, The American journal of clinical nutrition.

Nutritional risk factors for SARS-CoV-2 infection: a prospective study within the NutriNet-Santé cohort

X. de Lamballerie, G. Severi, M. Touvier, 2021, BMC Medicine.

Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: the EPIB 2008 study.

F. Carrat, P. Morlat, S. Pol, 2010, Journal of hepatology.

Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin.

F. Carrat, S. Pol, N. Lapidus, 2008, AIDS.

[Surgical site infections after cesarean section: results of a five-year prospective surveillance].

B. Carbonne, F. Barbut, J. Milliez, 2004, Journal de gynecologie, obstetrique et biologie de la reproduction.

High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?

F. Carrat, S. Pol, P. Cacoub, 2007, AIDS.

Risk factors for anaemia in human immunodeficiency virus/hepatitis C virus‐coinfected patients treated with interferon plus ribavirin

F. Carrat, S. Pol, P. Cacoub, 2007, Journal of viral hepatitis.

Segregation of HLA-DR2 among affected and non-affected offspring of 66 families with Type 1 (insulin-dependent) diabetes

M. Busson, D. Cohen, I. Deschamps, 1984, Diabetologia.

Long-Term Outcome and Treatment Modifications in a Prospective Cohort of Human Immunodeficiency Virus Type 1-Infected Patients on Triple-Drug Antiretroviral Regimens

W. Rozenbaum, M. Guiguet, P. Jaillon, 2000 .

Long-term outcome and treatment modifications in a prospective cohort of human immunodeficiency virus type 1-infected patients on triple-drug antiretroviral regimens. Triest Cohort Investigators.

W. Rozenbaum, M. Guiguet, P. Jaillon, 2000, Clinical Infectious Diseases.

Antibody response, associated symptoms and profile of patients presumably infected by SARS-CoV-2 with taste or smell disorders in the SAPRIS multicohort study

G. Severi, M. Touvier, M. Zins, 2023, BMC Infectious Diseases.

Management of chronic hepatitis C in French departments of internal medicine and infectious diseases

F. Carrat, D. Ouzan, P. Morlat, 2005, Epidemiology and Infection.

Changes in the Profile and Care of HIV-HCV Seropositive Patients in TwoCross-Sectional Surveys in France (2006 and 2013)

P. Morlat, S. Pol, P. Cacoub, 2014 .

Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis

V. de Lédinghen, J. Zucman‐Rossi, M. Ronot, 2021, JHEP reports : innovation in hepatology.

Factors associated with intensity of symptoms in patients seeking medical advice for flu

F. Carrat, A. Valleron, I. Goderel, 2004 .

Age, COVID-19-like symptoms and SARS-CoV-2 seropositivity profiles after the first wave of the pandemic in France

G. Severi, M. Touvier, M. Zins, 2021, Infection.

558 Risk factors for bacterial infections in HIV/HCV-coinfected patients during interferon plus ribavirin-based therapy

F. Carrat, S. Pol, P. Cacoub, 2006 .

Culture-independent characterisation of human faecal flora using rRNA-targeted hybridisation probes

J. Doré, P. Pochart, G. Gramet, 1998, Genetics Selection Evolution.